dc.contributor.author | Timothy, JWS | |
dc.contributor.author | Klas, N | |
dc.contributor.author | Sanghani, HR | |
dc.contributor.author | Al-Mansouri, T | |
dc.contributor.author | Hughes, ATL | |
dc.contributor.author | Kirshenbaum, GS | |
dc.contributor.author | Brienza, V | |
dc.contributor.author | Belle, MDC | |
dc.contributor.author | Ralph, MR | |
dc.contributor.author | Clapcote, SJ | |
dc.contributor.author | Piggins, HD | |
dc.date.accessioned | 2018-04-09T10:24:10Z | |
dc.date.issued | 2017-05-20 | |
dc.description.abstract | BACKGROUND: Alterations in environmental light and intrinsic circadian function have strong associations with mood disorders. The neural origins underpinning these changes remain unclear, although genetic deficits in the molecular clock regularly render mice with altered mood-associated phenotypes. METHODS: A detailed circadian and light-associated behavioral characterization of the Na+/K+-ATPase α3 Myshkin (Myk/+) mouse model of mania was performed. Na+/K+-ATPase α3 does not reside within the core circadian molecular clockwork, but Myk/+ mice exhibit concomitant disruption in circadian rhythms and mood. The neural basis of this phenotype was investigated through molecular and electrophysiological dissection of the master circadian pacemaker, the suprachiasmatic nuclei (SCN). Light input and glutamatergic signaling to the SCN were concomitantly assessed through behavioral assays and calcium imaging. RESULTS: In vivo assays revealed several circadian abnormalities including lengthened period and instability of behavioral rhythms, and elevated metabolic rate. Grossly aberrant responses to light included accentuated resetting, accelerated re-entrainment, and an absence of locomotor suppression. Bioluminescent recording of circadian clock protein (PERIOD2) output from ex vivo SCN revealed no deficits in Myk/+ molecular clock function. Optic nerve crush rescued the circadian period of Myk/+ behavior, highlighting that afferent inputs are critical upstream mediators. Electrophysiological and calcium imaging SCN recordings demonstrated changes in the response to glutamatergic stimulation as well as the electrical output indicative of altered retinal input processing. CONCLUSIONS: The Myshkin model demonstrates profound circadian and light-responsive behavioral alterations independent of molecular clock disruption. Afferent light signaling drives behavioral changes and raises new mechanistic implications for circadian disruption in affective disorders. | en_GB |
dc.description.sponsorship | This work was supported by Biotechnology and Biological Sciences Research Council Grant Nos. BB/L007665 and BB/M02329X (to HDP); Wellcome Trust Grant No. WT092319MA (to HDP); Human Frontiers of Science Programme Grant No. RGP0024/2012 (to HDP); Natural Sciences and Engineering Research Council of Canada Grant No. 170040 (to MRR); an interdisciplinary PhD studentship from the University of Manchester (to JWST); a Ph.D. scholarship from the King Abdulaziz University, Saudi Arabia (to TA-M); a research studentship from the Ontario Mental Health Foundation (to GSK); and a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression (to SJC). | en_GB |
dc.identifier.citation | Awaiting citation | en_GB |
dc.identifier.doi | 10.1016/j.biopsych.2017.04.018 | |
dc.identifier.uri | http://hdl.handle.net/10871/32381 | |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/28689605 | en_GB |
dc.rights | © 2017 Society of Biological Psychiatry. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/). | en_GB |
dc.subject | Bipolar | en_GB |
dc.subject | Circadian | en_GB |
dc.subject | Light | en_GB |
dc.subject | Mania | en_GB |
dc.subject | Mood | en_GB |
dc.subject | Suprachiasmatic | en_GB |
dc.title | Circadian Disruptions in the Myshkin Mouse Model of Mania Are Independent of Deficits in Suprachiasmatic Molecular Clock Function. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2018-04-09T10:24:10Z | |
dc.identifier.issn | 0006-3223 | |
exeter.place-of-publication | United States | en_GB |
dc.description | This is the final version of the article. Available from Elsevier via the DOI in this record. | en_GB |
dc.identifier.journal | Biological Psychiatry | en_GB |